Last updated: 11/04/2018 05:40:48

A Multiple Use Tolerability study of a Breathe Right Nasal Strip Prototype

GSK study ID
B3560692
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A Multiple Use Tolerability study of a Breathe Right Nasal Strip Prototype
Trial description: This study evaluated the safety & tolerability of two Breathe Right nasal strip prototypes. Prototypes were produced as an improvement to the currently marketed product.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Single (Participant)
Allocation:
Randomized
Primary outcomes:

Dermal response score of the application site of the nasal strip

Timeframe: Baseline through 7 days

Secondary outcomes:

Subjective questionnaire regarding comfort, overnight adherence, and ease of removal of the strip

Timeframe: 7 days

Interventions:
Device: Marketed Nasal Strip
Device: Prototype Nasal Dilator
Enrollment:
80
Observational study model:
Not applicable
Primary completion date:
2009-30-11
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Healthy Subjects
Product
Breathe Right
Collaborators
Not applicable
Study date(s)
November 2009 to November 2009
Type
Interventional
Phase
1

Participation criteria

Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
Yes
  • Inclusion Criteria:
  • Healthy subjects

Trial location(s)

Location
Status
Contact us
Contact us
Location
Essex Testing Clinic, Inc
Verona, NJ, United States, 07044
Status
Study Complete

Study documents

No study documents available.

Results overview

Study Results yet to be posted

Recruitment status
Completed
Actual primary completion date
2009-30-11
Actual study completion date
2009-30-11

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website